Nasdaq

Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test

20-08-2018

Albuquerque and San Diego, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test, see full press release here.

http://www.prnewswire.com/news-releases/carefirst-and-exagen-diagnostics-announce-evidence-development-agreement-for-avise-lupus-diagnostic-test-300699103.html

CONTACT: Brian McEvilly
Exagen Diagnostics, Inc.
858-736-5517
bmcevilly@exagen.com